您的购物车当前为空
MRT-2359 是一种有效的且可口服的 GSPT1 降解剂,具有抗肿瘤活性。MRT-2359 对耐药非小细胞肺癌 (NSCLC) 和小细胞肺癌 (SCLC) 细胞的生长具有抑制作用。MRT-2359 在 MYC 驱动的细胞系中表现出优先活性。


为众多的药物研发团队赋能,
让新药发现更简单!
MRT-2359 是一种有效的且可口服的 GSPT1 降解剂,具有抗肿瘤活性。MRT-2359 对耐药非小细胞肺癌 (NSCLC) 和小细胞肺癌 (SCLC) 细胞的生长具有抑制作用。MRT-2359 在 MYC 驱动的细胞系中表现出优先活性。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 477 | In Stock | |
| 5 mg | ¥ 1,160 | In Stock | |
| 10 mg | ¥ 1,880 | In Stock | |
| 25 mg | ¥ 3,560 | In Stock | |
| 50 mg | ¥ 4,970 | In Stock | |
| 100 mg | ¥ 6,860 | In Stock | |
| 200 mg | ¥ 9,430 | In Stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 1,260 | In Stock |
MRT-2359 相关产品
| 产品描述 | MRT-2359 is a potent and orally available GSPT1 reducer with antitumour activity.MRT-2359 inhibits the growth of drug-resistant non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) cells.MRT-2359 exhibits preferential activity in MYC-driven cell lines. |
| 分子量 | 495.38 |
| 分子式 | C22H17F4N3O6 |
| CAS No. | 2803881-11-8 |
| Smiles | O=C1N(CC=2C1=CC(COC(NC3=CC(OC(F)(F)F)=CC=C3F)=O)=CC2)C4C(=O)NC(=O)CC4 |
| 密度 | 1.548 g/cm3 at 20℃ (Predicted) |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | store at low temperature,keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 25 mg/mL (50.47 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
评论内容